Simultaneous Treatment of Moderate-to-Severe Horizontal Frontalis Lines, Glabellar Lines, and Lateral Canthal Lines wtih OnabotulinumtoxinA from the Subject’s Perspective: Patient-Reported Satisfaction and Impact Outcomes from a Phase 3 Double-Blind Study. J of Skin [Internet]. 2017 Oct. 27 [cited 2025 Apr. 20];1(3.1):s88. Available from: https://skin.dermsquared.com/skin/article/view/89